Biomarkers · Anthropometric
Fat-Free Mass
Higher values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).
Fat-Free Mass and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to the curve's reference value, drawn from the published study (source below).
Fat-Free Mass by age and sex
Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.
The percentiles as a table
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 35.4 | 44.4 | 54.2 | 64.4 | 77.5 | 1,504 | NHANES 2005-2006 |
| All | 40-59 | 37.2 | 44.1 | 55.2 | 64.4 | 78.3 | 1,433 | NHANES 2005-2006 |
| All | 60-69 | 34.6 | 42.7 | 50.7 | 61.4 | 74.4 | 647 | NHANES 2005-2006 |
| All | all | 36.0 | 44.0 | 54.1 | 64.0 | 77.5 | 3,584 | NHANES 2005-2006 |
| Men | 20-39 | 49.0 | 56.5 | 62.8 | 70.0 | 83.3 | 797 | NHANES 2005-2006 |
| Men | 40-59 | 50.2 | 58.3 | 64.0 | 70.8 | 82.3 | 712 | NHANES 2005-2006 |
| Men | 60-69 | 46.5 | 55.9 | 61.4 | 68.2 | 75.9 | 324 | NHANES 2005-2006 |
| Men | all | 48.8 | 57.3 | 63.3 | 70.2 | 81.9 | 1,833 | NHANES 2005-2006 |
| Women | 20-39 | 33.6 | 38.5 | 43.9 | 49.4 | 59.7 | 707 | NHANES 2005-2006 |
| Women | 40-59 | 35.6 | 39.8 | 44.6 | 50.7 | 61.5 | 721 | NHANES 2005-2006 |
| Women | 60-69 | 33.4 | 38.6 | 43.9 | 48.5 | 58.7 | 323 | NHANES 2005-2006 |
| Women | all | 34.3 | 39.2 | 44.2 | 49.9 | 60.5 | 1,751 | NHANES 2005-2006 |
What studies found when this marker was changed
They describe what happened in those study groups, not a recommendation. See all catalogued interventions.
Measured changes in Fat-Free Mass, study by study
4 effects with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Green points move the marker the way lower risk of death lies; amber the other way. Study results in the groups studied, not predictions for a person.
| Type | Intervention | Reported effect | Evidence | Source |
|---|---|---|---|---|
| supplement | Dietary protein supplementation during >=6 weeks of resistance exercise training in healthy adults | Additional FFM gain of 0.30 kg (95% CI 0.09-0.52) during resistance training | meta-analysis | Morton RW, et al. Br J Sports Med. 2018. A systematic review, meta-analysis and… |
| supplement | Creatine monohydrate (~7 g or 0.3 g/kg/day) combined with resistance training in adults under 50 | Lean body mass +1.14 kg (95% CI 0.69-1.59) vs resistance training alone; fat mass -0.73 kg | meta-analysis | Desai I, Wewege MA, Jones MD, et al. J Strength Cond Res. 2024. |
Things that worsen it
| Type | Condition or exposure | Reported effect | Evidence | Source |
|---|---|---|---|---|
| diet | Restricting eating to a 10-hour window daily for 8 weeks in college-age adults with overweight/obesity | Fat-free mass -2.3 kg with TRE alone over 8 weeks; +1.6 kg with resistance training; maintained with TRE+RT | RCT | Cui T, et al. J Int Soc Sports Nutr. 2025. Efficacy of time restricted eating… |
| pharmacologic | GLP-1 receptor agonist therapy in adults with diabetes and/or overweight/obesity (22 RCTs) | Lean mass -0.86 kg (95% CI -1.30 to -0.42), about 25% of total weight lost (-3.55 kg) | meta-analysis | Karakasis P, Patoulias D, Fragakis N, et al. Metabolism. 2025. |
What else moves this marker
They describe those study groups, not an individual, and an association is not a cause.
Environmental and occupational exposures
| What | Effect on the marker | Comparison · population | Source |
|---|---|---|---|
| ↑ Fetal cannabis exposure · any cannabinoid detected in maternal urine at ~27 weeks' gestation | +1.2 kg (95% CI 0.4 to 2) | exposed vs non-exposed offspring at mean age 4.7 years · 103 mother-child pairs from the Healthy Start cohort, Colorado; ~15% exposed | prospective cohort · PMID 35357471 |
Sources
- Risk curve: Haas 2026 (PMID 42430205): all-cause RR 1.42 (1.3-1.55) low versus high fat-free mass (study-specific categories). Scaled to US values (NHANES).
- Haas et al. Association Between Fat-Free Mass and Mortality: A Systematic Review and Meta-Analysis. Journal of cachexia, sarcopenia and muscle. 2026;17:e70331.
Map Fat-Free Mass against another biomarker.
Related markers: Appendicular Lean Mass / Sarcopenia Index · Basal Metabolic Rate · Body Fat Percentage · Body Mass Index (BMI) · Body Weight · Calf Circumference · Fat Mass · Gait Speed